HKU Scholars Hub: Browsing DSpace

Browsing by Author Lau, JSM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 8 of 8

	Title	Author(s)	Issue Date	Views
	Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis Journal:Hematology	Singh, GHH Leung, AYH Chan, CC Lau, JSM Chan, C Yip, SF Liu, H Kho, B Mak, V Lee, HKK Lin, SY Lau, CK Kwong, YL	2015	83
	Clofarabine, Cytarabine And Mitoxantrone (CLAM) for relapsed or refractory acute myeloid leukaemia - interim results of a prospective phase 2 study Proceeding/Conference:Congress of the European Haematology Association	Singh, GHH Ip, HW Yip, SF Kho, CSB Lee, KKH Mak, V Lau, JSM Lau, CK Lin, SY Wong, SMR Li, W Kwong, YL	2017	135
	Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations Journal:American Journal of Hematology	Leung, GMK Zhang, C Ng, NKL Yang, N Lam, SSY Au, CH Chan, TL Ma, ESK Tsui, SP Ip, HW So, JCC Ng, MHL Cheng, KCK Wong, KF Siu, LLP Yip, SF Lin , SY Lau, JSM Luk , TH Lee , HKK Lau, CK Kho, B Kwong, YL Leung, AYH	2019	12
	Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study Journal:Cancer	Singh, GHH Yim, RLH Lee, HKK Mak, V Lin, SY Kho, B Yip, SF Lau, JSM Li, W Ip, HW Hwang, YYG Chan, SYT Tse, EWC Au, WY Kumana, CR Kwong, YL	2018	90
	A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study Proceeding/Conference:Journal of Clinical Oncology	Yau, TCC Cheung, FY Lee, F Choo, SP Wong, HYH Toh, HC Leung, AK Chan, P Yau, TK Wong, J Tang, YF Lau, JSM Cheung, TT Fan, ST Poon, RTP	2013	274
	Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome Journal:Blood Cancer Journal	CHER, CY LEUNG, GMK AU, CH CHAN, TL MA, ESK Sim, PYJ Singh, GHH Lie, AKW Liang, RHS WONG, KF SIU, LLP TSUI, CSP So, JCC WONG, HWW YIP, SF LEE, HKK LIU, HSY LAU, JSM LUK, TH LAU, TK LIN, SY Kwong, YL Leung, AYH	2016	95
	Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study Journal:Cancer	Singh, GHH Kumana, CR Yim, RLH Hwang, YYG Chan, SYT Yip, SF Lee, HKK Mak, V Lau, JSM Chan, CC Kho, B Wong, RSM Li, W Lin, SY Lau, CK Ip, HW Leung, RYY Lam, CCK Kwong, YL	2019	31
	Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: A 10-year follow-up study Journal:Blood	Au, WY Kumana, CR Lee, HKK Lin, SY Liu, H Yeung, DYM Lau, JSM Kwong, YL	2011	100

Showing results 1 to 8 of 8